Release Date: 29/09/14 09:26 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 198.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%